Health Care: Drugs

StemCells Inc (STEM: NASDAQ)

$0.8985 0.0253 | 2.9%
12/24/14 - 01:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.20M 1.37M 1.22M 1.43M
Cost of Sales 316.63K 263.19K 214.81K 168.42K
Gross Operating Profit 886.64K 1.10M 1.01M 1.26M
Selling, General, and Administrative Expenses 8.90M 7.45M 8.20M 9.38M
Research & Development 20.53M 15.85M 19.94M 21.02M
Operating Income before D & A (EBITDA) -28.54M -22.19M -27.13M -29.14M
Depreciation & Amortization 1.35M 991.72K 1.21M 1.52M
Interest Income 11.32K 15.59K 13.94K 26.73K
Other Income - Net 3.32M -5.91M 6.81M 4.18M
Special Income / Charges -61.84K -356.38K -942.08K -221.99K
Total Income Before Interest Expenses (EBIT) -26.62M -29.43M -22.47M -26.67M
Interest Expense 1.17M 50.19K 71.36K 93.38K
Pre-Tax Income -27.79M -29.48M -22.54M -26.76M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -26.44M -28.49M -21.33M -25.24M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -26.44M -28.49M -21.33M -25.24M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -26.44M -28.49M -21.33M -25.24M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-26.38M -28.13M -20.39M -25.02M
Preferred Dividends
Net Income Available To Common -26.44M -28.49M -21.33M -25.24M
Basic EPS from Continuing Ops. -0.61 -0.99 -1.50 -2.05
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.61 -0.99 -1.50 -2.05
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.05
Basic EPS, Total -0.61 -0.99 -1.50 -2.00
Basic Normalized Net Income/Share -0.61 -0.98 -1.44 -2.03
EPS fr Continuing Ops. -0.61 -0.99 -1.50 -2.05
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.61 -0.99 -1.50 -2.05
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.05
EPS, Total -0.61 -0.99 -1.50 -2.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.61 -0.98 -1.44 -2.03
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with STEM

Latest STEM Headlines from TheStreet

More Financial News for STEM

Press Releases for STEM

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter